tickrz reports
Gilead Sciences Inc (GILD)
Healthcare | Drugs
74.19  -0.04%
GILD vs DRUGS SECTOR & S&P 500
VALUATION
GILDSECTORS&P 500
P/E RATIO8.443820.18
EV/EBITDA RATIO4.9121.612.15
P/S RATIO3.566.22.14
P/B RATIO3.947.33.29
QUALITY
RETURN ON EQUITY54.34%15.79%13.65%
RETURN ON CAPITAL92.38%19.38%10.09%
NET MARGIN44.53%14.46%9.76%
DIVIDEND ANALYSIS
DIVIDEND YIELD
2.74%
PAYOUT RATIO23.82%
3 YR DIVIDEND GROWTHN/A
FINANCIAL STRENGTH
PIOTROSKI F SCORE
4 OUT OF 9
DEBT-TO-EQUITY116%
INTEREST COVERAGE14.6x
CURRENT RATIO3.68
GROWTH
5 YR EPS GROWTH41.14%
5 YR SPS GROWTH29.07%
5 YR BPS GROWTH26.37%
Gilead Sciences Inc Filings

Annual & Quarterly Reports

Events or Changes Between Quarters (8-K)


Changes in Ownership